ATE330968T1 - Cyclosporin-derivate und verfahren zu deren herstellung - Google Patents

Cyclosporin-derivate und verfahren zu deren herstellung

Info

Publication number
ATE330968T1
ATE330968T1 AT00901297T AT00901297T ATE330968T1 AT E330968 T1 ATE330968 T1 AT E330968T1 AT 00901297 T AT00901297 T AT 00901297T AT 00901297 T AT00901297 T AT 00901297T AT E330968 T1 ATE330968 T1 AT E330968T1
Authority
AT
Austria
Prior art keywords
production
derivatives
cyclosporine derivatives
relates
cyclosporine
Prior art date
Application number
AT00901297T
Other languages
English (en)
Inventor
Manfred Mutter
Roland M Wenger
Jean-Francois Guichou
De Chimie Batiment
Michael Keller
Chemistry
Thomas Ruckle
Torsten Woehr
Original Assignee
Debiopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm Sa filed Critical Debiopharm Sa
Application granted granted Critical
Publication of ATE330968T1 publication Critical patent/ATE330968T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00901297T 1999-02-05 2000-02-07 Cyclosporin-derivate und verfahren zu deren herstellung ATE330968T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH22099 1999-02-05

Publications (1)

Publication Number Publication Date
ATE330968T1 true ATE330968T1 (de) 2006-07-15

Family

ID=4182021

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00901297T ATE330968T1 (de) 1999-02-05 2000-02-07 Cyclosporin-derivate und verfahren zu deren herstellung

Country Status (10)

Country Link
US (1) US6790935B1 (de)
EP (1) EP1150999B1 (de)
AT (1) ATE330968T1 (de)
AU (1) AU2125300A (de)
CY (1) CY1105452T1 (de)
DE (1) DE60028936T2 (de)
DK (1) DK1150999T3 (de)
ES (1) ES2267492T3 (de)
PT (1) PT1150999E (de)
WO (1) WO2000046239A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60208180T2 (de) * 2001-04-20 2006-08-17 Debiopharm S.A. Modifiziertes, als medikamentvorstufe anwendbares cyclosporin und dessen verwendung
US8889629B2 (en) * 2005-01-10 2014-11-18 Debiopharm International Sa Use of a cyclic undecapeptide for the preparation of a medicament for administration during myocardial ischaemic events
BRPI0605658B8 (pt) * 2006-12-29 2021-05-25 Embrapa Pesquisa Agropecuaria peptídeo antibiótico rico em glicina derivado de planta
US8153815B2 (en) * 2008-10-07 2012-04-10 Hoffman-La Roche Inc. Pseudoproline dipeptides
ES2921576T3 (es) 2008-12-19 2022-08-29 Vertex Pharma Compuestos útiles como inhibidores de la quinasa ATR
US8367053B2 (en) * 2009-07-09 2013-02-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8349312B2 (en) * 2009-07-09 2013-01-08 Enanta Pharmaceuticals, Inc. Proline substituted cyclosporin analogues
US8685917B2 (en) * 2009-07-09 2014-04-01 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
EP2569313A1 (de) 2010-05-12 2013-03-20 Vertex Pharmaceuticals Incorporated Als art-kinasehemmer nützliche verbindungen
LT2651965T (lt) 2010-12-15 2019-01-10 Contravir Pharmaceuticals, Inc. Ciklosporino analogo molekulės su modifikuotomis 1 ir 3 aminorūgštimis
RU2018108589A (ru) 2011-09-30 2019-02-25 Вертекс Фармасьютикалз Инкорпорейтед Лечение рака поджелудочной железы и немелкоклеточного рака легкого ингибиторами atr
EP3878851A1 (de) 2011-09-30 2021-09-15 Vertex Pharmaceuticals Incorporated Verfahren zur herstellung von verbindungen welche als hemmer der atr-kinase nützlich sind
PT2833973T (pt) 2012-04-05 2017-12-21 Vertex Pharma Compostos úteis como inibidores da cinase atr e terapias de combinação dos mesmos
AR090964A1 (es) * 2012-05-09 2014-12-17 Novartis Ag Proceso para la elaboracion de undecapeptidos ciclicos
CA2874548A1 (en) 2012-06-01 2013-12-05 Allergan, Inc. Cyclosporin a analogs
WO2014055756A1 (en) 2012-10-04 2014-04-10 Vertex Pharmaceuticals Incorporated Method for measuring atr inhibition mediated increases in dna damage
WO2016112321A1 (en) 2015-01-08 2016-07-14 Allergan, Inc. Cyclosporin derivatives wherein the mebmt sidechain has been cyclized
EP3355926B1 (de) 2015-09-30 2025-12-24 Vertex Pharmaceuticals Inc. Kombination von dna-schädigenden mitteln und atr-inhibitoren zur verwendung in einem verfahren zur behandlung von krebs
CN107176970B (zh) * 2017-07-06 2019-11-19 中国医药集团总公司四川抗菌素工业研究所 一种树脂催化法合成伪脯氨酸杂环肽的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE43335T1 (de) * 1980-02-14 1989-06-15 Sandoz Ag Peptide die einen (1s,2r,3r)- oder (1r,2s,3s)-1nitrilo-1-carbonyl-3-methyl-2-oxyheptan oder hept-5-en-rest enthalten brauchbar in totaler synsthese von cyclosporinen, und verfahren zu ihrer herstellung.
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
GB8717300D0 (en) * 1987-07-22 1987-08-26 Nat Res Dev Cyclosporins
USRE40987E1 (en) * 1998-07-01 2009-11-17 Debiopharm S.A. Cyclosporin with improved activity profile

Also Published As

Publication number Publication date
EP1150999B1 (de) 2006-06-21
PT1150999E (pt) 2006-10-31
AU2125300A (en) 2000-08-25
ES2267492T3 (es) 2007-03-16
DK1150999T3 (da) 2006-10-30
US6790935B1 (en) 2004-09-14
EP1150999A1 (de) 2001-11-07
CY1105452T1 (el) 2010-04-28
DE60028936D1 (de) 2006-08-03
DE60028936T2 (de) 2007-01-11
WO2000046239A1 (fr) 2000-08-10

Similar Documents

Publication Publication Date Title
ATE330968T1 (de) Cyclosporin-derivate und verfahren zu deren herstellung
DE69803721D1 (de) P-typ Stickstoff-Verbindungshalbleiter und Verfahren zu dessen Herstellung
NO20020348D0 (no) Peptid acceptor ligeringsmetoder
DE60011875D1 (de) System und verfahren zum ermöglichen sicherer verbindungen für h.323 voip anrufe
ATE440863T1 (de) Chemokine peptide, varianten, derivate und analoge. ihre verwendung in methode für die hemmung oder erhíhung von einer entzündungsreaktion
DE69812489D1 (de) Korrosionsbeständiges Bauteil, Waferträger und Verfahren zu deren Herstellung
ATE327443T1 (de) Befestigungsmittel und verfahren zu seiner herstellung
DK1091975T3 (da) Ny cyclosporin med forbedret aktivitetsprofil
NO20014508D0 (no) Fremgangsmåte for acylering av peptider, og nye acyleringsmidler
DZ2196A1 (fr) Compositions nanoparticulaires de cyclosporine a.
FI980862A0 (fi) Kiraalisia metyylifenyylioksatsolidinoneja
DK0909312T3 (da) Fremgangsmåde til fremstilling af polypeptider
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
DE69906938D1 (de) Glococorticoid selektive entzündungshemmende mittel
ATE509886T1 (de) Peptidnanostrukturen, verfahren zu deren herstellung und verwendung
ATE398630T1 (de) Zyklische conotoxin-peptide
ATE313557T1 (de) Modifiziertes, als medikamentvorstufe anwendbares cyclosporin und dessen verwendung
TR199801954T2 (xx) Eprosartan dihidrat ve �retimi ve form�lasyonu i�in bir proses.
CY1111802T1 (el) Πρωτεϊνη συμμετεχουσα σε αποκατασταση γονιμοτητας φυτου με κυτταροπλασματικη ανδροστειροτητα και γονιδιο που την κωδικοποιει
DE60023860D1 (de) Verfahren zur herstellung von rekombinanten peptiden
DE69820184D1 (de) Lichtemittierendes Halbleiterbauelement und Verfahren zu dessen Herstellung
GB9914045D0 (en) Novel compounds
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE60034885D1 (de) Enzymlauge und verfahren zu deren herstellung, enzymzubereitung, proteasezubereitungen und proteaseproduzierendes bakterium
IL139604A (en) Fibrinogen-beta chain derived peptide, compositions comprising same and use thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1150999

Country of ref document: EP

REN Ceased due to non-payment of the annual fee